Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel

NCT01686048 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.

NCT NCT01686048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01686048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel
Lead sponsor
Meir Medical Center
Phase
Observational
Overall status
Completed
Start date
April 30, 2015
Completion date
April 30, 2015
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic conjunctivitis, allergic rhinitis, asthma, atopic dermatitis